Specifically, ASA successfully lobbied the Senate Committee on Health, Education, Labor and Pensions to include language in the bill that would require manufacturers to notify the FDA when there is a shortage of a “sterile injectable product” or a drug “used in emergency medical care or during surgery.”
Anesthetic and central nervous system drugs now account for 23 percent of drug shortages nationwide.
Related Articles on Anesthesia:
Stricter Guidelines Needed for Blood Transfusions, Study Says
Anesthesiologist Who Developed Checklist Protocol Receives ABMS Award
Anesthesiologists Are Top Earners in Pennsylvania
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
